Frontier technology is our best shot at solving humanity’s most pressing challenges. But how do these companies get built? Near Frontier takes you behind the scenes where the world’s most innovative companies work towards mitigating disease, climate change, and x-risk. We talk to founders, investors, and operators to bring you unfiltered stories on how deep tech companies come to life and most importantly, give us hope for the future.
Near Frontier is brought to you by Cantos, a venture firm that invests in world-positive deep tech startups at pre-seed and seed. To learn more, visit www.cantos.vc or find us on Twitter @CantosVC.
All content for Near Frontier is the property of Cantos Ventures and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Frontier technology is our best shot at solving humanity’s most pressing challenges. But how do these companies get built? Near Frontier takes you behind the scenes where the world’s most innovative companies work towards mitigating disease, climate change, and x-risk. We talk to founders, investors, and operators to bring you unfiltered stories on how deep tech companies come to life and most importantly, give us hope for the future.
Near Frontier is brought to you by Cantos, a venture firm that invests in world-positive deep tech startups at pre-seed and seed. To learn more, visit www.cantos.vc or find us on Twitter @CantosVC.
Synthetic Biology and Biomanufacturing with Joshua Britton from Debut Biotech
Near Frontier
56 minutes 28 seconds
3 years ago
Synthetic Biology and Biomanufacturing with Joshua Britton from Debut Biotech
Today we're joined by Dr. Joshua Britton, founder and CEO of Debut Biotech, a cell-free biomanufacturing company. Josh gives us a crash course on synthetic biology and biomanufacturing, walking us through the various methods and promise of this industry that may very well shift industrial production away from fossil fuels. We also get into some of the founding story of Debut, including how Cantos' investment in Debut came to be...hint: it had to do with a cold message.
Shownotes:
Power: Limits and Prospects foor Human Survial by Richard Heinberg
McKinsey report on synthetic biology
Debut Biotech on Twitter
Near Frontier
Frontier technology is our best shot at solving humanity’s most pressing challenges. But how do these companies get built? Near Frontier takes you behind the scenes where the world’s most innovative companies work towards mitigating disease, climate change, and x-risk. We talk to founders, investors, and operators to bring you unfiltered stories on how deep tech companies come to life and most importantly, give us hope for the future.
Near Frontier is brought to you by Cantos, a venture firm that invests in world-positive deep tech startups at pre-seed and seed. To learn more, visit www.cantos.vc or find us on Twitter @CantosVC.
